We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

Israeli scientists aim to mobilize allergy-causing cells to fight cancer

14 14 8
13.09.2021

Israeli scientists are harnessing the “destructive” qualities of allergy-causing cells, as part of a bold attempt to pioneer a new immunotherapy for fighting cancer.

A research team from Tel Aviv University has found that eosinophils, white blood cells that induce allergies, significantly reduce the growth of human tumors in vitro, and mouse tumors in the body.

Nine days after mice were injected with eosinophils, the overall size of tumors per mouse averaged half that of mice who weren’t injected.

Some past studies have suggested that eosinophils may combat cancer, but Prof. Ariel Munitz says that his research gives the clearest picture of their potential, and that his team is the first to start developing an eosinophil-based immunotherapy.

The development is just getting underway and is likely to take years, but is exciting as it could offer a “double bullet” treatment against cancer, said Munitz.

This is because his research concluded that eosinophils fight tumors themselves, and also cause increased numbers of cancer-fighting T cells to........

© The Times of Israel


Get it on Google Play